---
title: "Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products with the Help of AI"
description: "Albert Invent has partnered with Kenvue Inc. to enhance R&D efforts across Kenvue's global brands using AI. This multi-year collaboration, starting in Q1 2025, aims to streamline and digitalize the pr"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261115909.md"
published_at: "2025-10-14T17:10:38.000Z"
---

# Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products with the Help of AI

> Albert Invent has partnered with Kenvue Inc. to enhance R&D efforts across Kenvue's global brands using AI. This multi-year collaboration, starting in Q1 2025, aims to streamline and digitalize the product lifecycle, improving efficiency for scientists by simplifying hundreds of R&D processes. The partnership focuses on leveraging Albert Invent's AI platform to better meet consumer needs and drive impactful results in the health products sector.

Frontier AI company Albert Invent announced a strategic partnership with Kenvue Inc, to accelerate end-to-end R&D efforts across the company?s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent's foundational AI models. The companies began working together starting in first quarter 2025 as part of a multi-year partnership set to drive value for scientists by streamlining hundreds of R&D processes and methodologies across the globe.

The focus of the partnership is to augment and accelerate the work of Kenvue's global workforce of scientists with Albert Invent's end-to-end AI platform, with the goal of simplifying processes to gain efficiencies both inside and outside of the lab and allowing these incredible scientists to meet evolving consumer needs with even greater impact.

### Related Stocks

- [KVUE.US - Kenvue](https://longbridge.com/en/quote/KVUE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here? | This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here? | [Link](https://longbridge.com/en/news/262291025.md) |
| Kimberly-Clark Files Registration Statement for Merger with Kenvue | Kimberly-Clark Corporation has announced a merger with Kenvue Inc., making Kenvue a wholly owned subsidiary. The merger  | [Link](https://longbridge.com/en/news/272884897.md) |
| EXPLAINER-Is Tylenol safe to take during pregnancy? | Consumer goods giant Kimberly-Clark plans to acquire Kenvue for over $40 billion, despite Kenvue facing lawsuits regardi | [Link](https://longbridge.com/en/news/264080046.md) |
| Buy Rating on Kenvue, Inc.: Promising Investment Amid Acquisition and Legal Challenges | Keith Devas has issued a Buy rating for Kenvue, Inc., citing its acquisition by Kimberly-Clark as a promising investment | [Link](https://longbridge.com/en/news/264102500.md) |
| Trump says not to give young children Tylenol | U.S. President Donald Trump on Friday urged pregnant women not to use Tylenol unless absolutely necessary and not to giv | [Link](https://longbridge.com/en/news/259097979.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.